ExodusPoint Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-145,919
| Closed | -$9.31M | – | 1864 |
|
|
2025
Q1 | $9.31M | Buy |
+145,919
| New | +$9.31M | 0.09% | 203 |
|
|
2024
Q4 | – | Sell |
-43,106
| Closed | -$5.38M | – | 1896 |
|
|
2024
Q3 | $5.38M | Sell |
43,106
-74,109
| -63% | -$9.26M | 0.03% | 360 |
|
|
2024
Q2 | $18.5M | Buy |
117,215
+12,062
| +11% | +$1.91M | 0.13% | 118 |
|
|
2024
Q1 | $13.6M | Buy |
105,153
+97,646
| +1,301% | +$12.6M | 0.1% | 126 |
|
|
2023
Q4 | $724K | Sell |
7,507
-79,906
| -91% | -$7.71M | ﹤0.01% | 859 |
|
|
2023
Q3 | $10.6M | Buy |
+87,413
| New | +$10.6M | 0.1% | 184 |
|
|
2023
Q2 | – | Sell |
-4,053
| Closed | -$559K | – | 2117 |
|
|
2023
Q1 | $559K | Sell |
4,053
-152,972
| -97% | -$21.1M | ﹤0.01% | 1213 |
|
|
2022
Q4 | $20.3M | Buy |
157,025
+129,515
| +471% | +$16.8M | 0.3% | 60 |
|
|
2022
Q3 | $3.04M | Sell |
27,510
-78,177
| -74% | -$8.64M | 0.04% | 559 |
|
|
2022
Q2 | $7.92M | Buy |
105,687
+91,319
| +636% | +$6.85M | 0.1% | 235 |
|
|
2022
Q1 | $1.12M | Sell |
14,368
-1,196
| -8% | -$93.4K | 0.01% | 1020 |
|
|
2021
Q4 | $1.4M | Buy |
+15,564
| New | +$1.4M | 0.01% | 871 |
|
|
2021
Q3 | – | Sell |
-14,862
| Closed | -$1.16M | – | 2521 |
|
|
2021
Q2 | $1.16M | Sell |
14,862
-21,626
| -59% | -$1.68M | 0.01% | 874 |
|
|
2021
Q1 | $2.72M | Buy |
+36,488
| New | +$2.72M | 0.04% | 426 |
|
|
2020
Q2 | – | Sell |
-2,409
| Closed | -$236K | – | 1971 |
|
|
2020
Q1 | $236K | Sell |
2,409
-4,067
| -63% | -$398K | 0.01% | 679 |
|
|
2019
Q4 | $836K | Buy |
+6,476
| New | +$836K | 0.02% | 574 |
|